TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Neutropenia
Researchers from University of Cologne publish new studies and findings in the area of neutropenia
November 25th, 2008
According to recent research from Cologne, Germany, "We discuss different strategies for the treatment of invasive fungal inflections (IFI) in high risk patients with a focus on patients experiencing profound and prolonged neutropenia, comprising those with acute myelogenous leukaemia (AML) or myelodysplastic syndrome (MDS) during remission induction chemotherapy and on patients Undergoing allogeneic haematopoietic stern cell transplantation (SCT). Among these patients, invasive aspergillosis (IA) is the most frequently observed form of IFI, as opposed to high risk intensive care unit (ICU) patients in whom an increased incidence of invasive candidiasis (IC) can be observed. In both...
Source: TB & Outbreaks Week (2008-11-25)
|
